Epstein-Barr virus: Pathological implications;Le virus d'Epstein-Barr: Implications en pathologie

Annales de Pathologie

Volumn 18, Issue 1, 1998, Pages 16-28

  Kafe H ^a   Wechsler, J ^a   Gaulard, P ^b   Gosselin, B ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Epstein Barr virus; Etiology; Histopathology; In situ hybridization; Lymphoma; Tumors

Indexed keywords

EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; REVIEW; SOUTHERN BLOTTING; VIRUS DIAGNOSIS; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BURKITT LYMPHOMA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISORDERS; TUMOR VIRUS INFECTIONS; VIRUS LATENCY;

EID: 0031939039     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. EPSTEIN MA, Acnovo BG, BARR YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964 ; 1: 702-3.
2. EPSTEIN MA, BARR YM. Cultivation In vitro of human lymphoblasts from Burkitt's malignant lymphoma. Lancet 1964 ; 1: 252-3.
3. MAGRATII I. The pathogcncsis of Burkitt's lymphoma. Ailv Cancer Res 1990 ; 55 : 133-270.
4. Wu T, MANN RB, EPSTEIN J et al. Abundant expression of EBER 1 small RNA in nasopharyngcal carcinoma : a morphologically distinctive target for detection of EBV in formallinfixed paraffin-embedded carcinoma specimens. Am J Palhol 1991-183: 1461-9.
5. ZUR HAUSEN H, SCHULTE-HOLTIIAUSEN H, KLEIN G ei al. EBV DNA in biopsies of Burkilt tumors and anaplastic carcinomas of the nasopharynx. Nature 1970 ; 228: 1056-8.
6. TOKUNAGA M, IMAI S, UnMURA Y et al. Epstein-Barr virus in adult T-cell leukemia-lymphoma. Am J Pathol 1993 ; 143 : 1263-69.
7. KAMEL OW, VAN DER RUN M, LEBRUN DP et al. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis. Hum Pathol 1994 ; 25 : 638-43.
8. RANDIIAWA PS, MAGNONE M, JORDAN M et al. Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferativc disease. Am J Surg Pathol 1996 ; 20: 563-71.
9. COHEN IJ. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 1991 ; 70 : 137-60.
10. RAPHAEL M, AUDOUIN J, LAMINE M et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Am J Clin Palhol 1994 ; 101 : 773-82.
11. SciiLAiFER D, BROUSSET P, ATTAL M et al. Bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AlDS-related lymphoma. Histopathology 1994 ; 25 : 77-82.
12. BAER R, BANKIER AT, BIGGIN MD et al. DNA sequence and expression of the B95-8 Epstein-Barr virus. Nature 1984 ; 310 : 207-21.
13. nd edn. New York : Raven Press, 1990 ; 1889-920.
14. SAVOIE A, PERPéTE CH, CARPENTIER L, JONCAS J, ALFIERI C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatrie transplant patients and risk of lympoproliferalive disease. Blood 1994 ;83: 2715-22.
15. ROCCIII G, DE FELICI A, RAGONA G, HEINZ A. Quantitative evaluation of Epstein-Barr virus infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Eng J Med 1977 ; 296 : 478.
16. IIDA K, NADLER L, NUSSENZWEIG V. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med 1983 ; 158: 1021.
17. FISCHER E, DELIBRIAS C, KAZATCIIKINE M. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Imnnmol 1991 ; 1-16: 865-9.
18. TSOUKAS CD AND LAMBRIS JD. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 1988 ; 18: 1299.
19. REYNES M, AUIîERT JP, COHEN JHM et al. Human follicular dendritic cells express CRI, CR2, and CR3 complement receptor antigens. J Immunol 1985 ; 135 : 2687.
20. KONETO T, FUKUDA J, YosiiiHARA T el al. Nasal natural killer (NK) cell lymphoma : report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen and comparative study of their phenotype and cytotoxicity with normal NK cells. BrJ Ilaematol 1995 ; 91: 355-61.
21. SIXBEY JYV AND YAO QY. Immunoglobulin A-induced shift of Epstcin-barr virus tissues tropism. Science 1992 ; 225 : 1578-80.
22. NIEDOBITEK G and YOUNG L. Epstein-Barr virus persistance and virus-associated tumors. Lancet 1994 ; 343 : 333-5.
23. GULLEY ML, RAPHAEL M, LUTZ CH et al. Epstein-Barr virus intecration in human lymphomas and lymphoid cells lines. Cancer 1992; 70: 185-91.
24. DILLNER J, KALLIN B. The Epstcin-Barr virus proteins. Adv in Cancer Res 19S8 ; 50 : 95-158.
25. ROWE M, ROWE DT, GREGORY CD et a!. Differences in B cells groth phcnotype reflect novel pattern of EBV latent gene expression in Burkitt's lymphoma cells. EMBOJ 1987; 6: 2743-51.
26. DELSOL G, BROUSSET P, CIIITTAL S, RIOAL-HUGUET F. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridation with biotinylated BamHIW probes in Hodgkin's disease. Am J Pathol 1992 ; 140:247-53.
27. STEWART JP, ARRAND JR. Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimen. Hum Palhol 1993 ; 24: 239-42.
28. COHEN JI, Picciiio OR, MOSIER DE. Epstein-Barr virus nuclear protein 2 is a critical determinant for growth tumor in SCI D mice and transformation in vitro. J Virol 1992 ; 66: 7555-9.
29. AMBINDER RF and MANN RS. Detection and caractcrization of Epstein-Barr virus in clinical specimens. Am J Palhol 1994 ; 145: 239-52.
30. RAAB-TRAUB N, SADLER R, HOOD EDWARDS R et al. EBV infection in naso-pharyngeal carcinoma : viral expression and strain variation. In the Epstein-Barr virus and associated diseases 1993. pp 467-75. Ed. Inserm.
31. WANG F, GREGORY CD, ROWE M et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Nail Aaul Sei USA 1987 ; 3452-6.
32. WANG F, TSANG S, KURILLA MG et al. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 1990 ; 64: 3407-3416.
33. WANG D, LIEBOVITZ D, KIEFF E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985 ; 43 : 831-40.
34. MILLER WE, EARP HS, RAAB TRAUB N. The Epstein-Barr virus latent membrane protéine 1 induces expression of the epidermal groth factor receptor. J Virol 1995 ; 69: 4390-8.
35. HENDERSON S, ROWE M, GREGORY C et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991 ;65: 1107-15.
36. FINKE J, LANGE W, MERTELSMANN R, DOLKEN G. Bcl-2 induction is part of the strategy of Epstein-Barr virus. Leukemia and Lymphoma 1994 ; 12 : 413-9.
37. KNECHT H, BACHMANN E, BROUSSET P et al. Deletions within the LMP-1 oncogene of EBV are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993 ; 82 : 2937-42.
38. GRATAMA JW, OOSTERVEER MAP et al. Eradication of EBV by allogenic bone marrow transplantation : implications for sites of viral latency. Proc. Natl. Acail. Sei. USA 1988 ; 85: 8693-6.
39. SIXBEY JW, NEDRUD JG, RAAB-TRAUB N et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Eng J Med 1984 ; 310: 1225-30.
40. BROUSSET P, KNECHT H, RUUIN B et al. Demonstration of EBV replication in Rccd-Sternbcrg cells of Hodgkin's disease. Blood 1993 ; 872-6.
41. KATZ BZ, SAINI U. Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoprolifcrative disorders. Am J Pathol 1992 ; 140: 1247-54.
42. MARTEL-LENOIR D, GRUNEWALD V, COCIIET C el al. Expression of Epstein-Barr virus transactivator, ZEBRA, in nasopharyngeal carcinoma tumor cells. In The EBV and associated diseases 1993. Ed Inserm. Vol 225 : pp 489-96.
43. PALLESEN G, HAMILTON-DUTOIT SJ, ROWE M et al. Expression of Epstein-Barr virus replicativc proteins in AIDS-relatcd non-hodgkin's lymphoma cells. J Pathol 1991 ; 765 : 289-99.
44. OUDEJANS JJ, VAN DER BRULE AJ, JiWA NM et al. BHRF1, the Epstein-Barr virus homologue of the bcl-2 protooncogcnc, is transcribed in EBV-associated B-ccll lymphomas and in reactive lymphocytes. Blood 1995 ; 86 : 1893-1902.
45. ViEiRA P, DE WAAL-MALEFYT R, DANG MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones : homology to Epstein-Barr virus open reading frame BCRF1.1'roc Natl Acad Sei USA 1991 ; 88: 1172-6.
46. SIXBEY JW. Epstein-Barr virus and epithelial cells. Adv Viral Oncol 1989 ; 8: 187-202.
47. THOMAS JA, FELIX DH, WRAY D, SOUTMAM JC, CUDIE HA, CRAWFORD DH. Epstein-Barr virus gene expression and epithelial cell différenciation in oral hairy leukoplasia. Am J Patlwl 1991; 759: 1369-80.
48. SANDVEJ K, KRENACS L, HAMILTON-DUTOIT SJ, RINDUM JL, PINDBORG JJ, PALLESEN G. Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplasia. Ilistopatlwlogy 1992 ; 20: 387-95.
49. HAMILTON-DUTOIT SJ, PALLESEN G. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopatliology 1994 ; 25 : 101-11.
50. GULLEY M, RAAB-TRAUB N. Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Patlwl LabMeilW)3;]17: 1115-20.
51. AUDOUIN J, PRéVôT S, BROULAND JP, MOLINA T, LE TOURNEAU A, DIEBOLD J. Apport des techniques d'immunohistochimie et d'hybridation in situ dans les affections dues ou associées au virus d'Epstein-Barr. Arch Anat Cytol Patlwl 1992; 40: 95-104.
52. WEISS LM, CIIEN YY, Liu XF and SHIBATA D. EBV and Hodgkin's disease. Am J Patlwl 1991 ; 759: 1259-65.
53. HAMILTON-DUTOIT ST, DELECLUSE HJ, RAPHAEL M et al. Detection of Epstein-Barr virus genomes in AlDS-related lymphomas : Sensitivity and specificity of in situ hybridization compared with Southern blotting. J Clin Patlwl 1991 ; 44: 676-80.
54. RAAB-TRAUB N. AND FLYNN K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986 ; 47: 8S3-9.
55. ANAGNOSTOPOULOS I, HERBST H, NIEDOBITECK G, STEIN H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989 ; 74: 810-6.
56. ZENG Y, ZHANG LG, Li HY et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 1985 ; 29: 139-41.
57. JOAB I, NICOLAS JC, SCIIWAAB G et al. Detection of antiEpstein-Barr-Virus trans-activator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 1991 ; 48: 647-9.
58. JOAB I, TRIKI H, DE SAINT MARTIN J, PERRICAUDET M and NICOLAS JC. Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J Infect Dis 1991 ; 163 : 53-6.
59. GUILDS CC, PARHAM DM, BERARD CW. Infectious mononucleosis. Am J Snrg Patlwl 1987. 11: 122-32.
60. GREGORY CD, MURRAY RJ, EDWARDS CF, RICKINSON AB. Down regulation of cell adhesion molecules L.FA3 and ICAM1 in Epstein-Barr virus positive Burkitt's lymphoma underlies tumor cell escape from virus specific toxicity T cell surveillance. J Exp Meil 1988 ; 767: 1811-20.
61. KLEIN G. Epstein-Barr virus, malaria, and Burkitt's lymphoma. ScandJ Inf Dis Stippl 1982 ; 36 : 15-23.
62. LENOIR GM, BORNKAMM GW. Burkitt's lymphoma, a human cancer model for the study of the multi-step development of cancer : Proposal for a new scenario. Adv Virol Oncol 1987 ; 7 : 173-206.
63. CHAN JC, YIP TTC, TSANG WYW a al. Detection of Epstein-Barr virus in Hodckin's disease occurinc in a oriental population. Hum Patlwl 1995 ; 26 : 314-31.
64. SUBAR H, NERI A, INGHIRANI G et al. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Illooil 1988 ; 72: 661-71.
65. GUETTIER C. Les proliférations lymphoïdes après transplantation d'organe. Ann Pathol 1992 ; 12 : 85-97.
66. MAC-MAIION E, GLASS J, HAYWARD SD et al. Epstcin-Barr virus in AIDS -related primary central nervous system lymphoma. Lancet 1991 ; 33S : 969-73.
67. NAKIILED RE, MANIVEL JC, COPENIIAVER CM, SUNG JH, STRICKLER JG. In situ hybridation for the detection of EpsteinBarr virus in central nervous system lymphomas. Cancer 1991 ; 67:444-8.
68. CAMILLERI-BROëT S, DAVI F, FEUILLARD J et al. High expression of latent membrane protein 1 of Epstein-Barr virus and bcl-2 oncoprotein in acquired immunodeficiency syndromerelated primary brain lymphomas. Blood 1995 ; 86 : 432-5.
69. AUDOUIN J, DIEBOLD J, PALLESEN G. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 1992 ; 767:381-4.
70. HERNDIER BG, SANCHEZ HC, CHANG L, CIIEN YY, WEISS LM. High prevalence of Epstein-Barr virus in the Recd-Sternberg cells of HIV-associated Hodgkin's disease. Am J Palhol 1993 ; 142 : 1073-9.
71. EMILIE D, RAPHAEL M, JOAB I ci al. In situ production of IL-6 and IL-10 in AIDS lymphomas. In the Epstein-Barr virus and associated diseases 1993. pp 657-63. Ed. Inserm.
72. GRIERSON H, PURTILO DT. Epstein-Barr virus infection in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 1987 ; 106 : 538-45.
73. JONCAS JH, Russo P, BROCIIU P et al. Epstein-Barr virus polymorphic B-cell lypmhoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol 1990 ; S : 378-84.
74. SAEDMUNDSEN AK, BERKEL AI, HENLE W et al. Epstein-Barr virus carrying lymphoma in a patient with ataxia tclanaiectasia. Br Mcd J 1981 ; 2S2 : 425-7.
75. LEE HARRIS N, JAFFE ES, STEIN H, BANKS PM, CHAN JKC, CLEARY ML et al. A revised european-american classification of lymphoid neoplasms : A proposal from the international lymphoma study group.. Blood 1994 ; 84: 1361-92.
76. WEISS LM, MOVAHED LA, WARNKE RA AND SKLAR JS. Detection of Epstein-Barr viral genomes in Reed-Sternbcrg cells of Hodgkin's disease. N EnglJ Med 1989 ; 320: 502-6.
77. MASON DY, BANKS PM, CHAN J, CLEARY ML, DELSOL G, DE WOLF PEETERS C et ni. Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. Am J Stirs Pathol 1994 ; IS : 526-30.
78. BROUSSET P, ROCHAIX P, CHITTAL S, RUBIE H, ROBERT A, DELSOL G. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large cell lymphoma in children, llistopathology 1993 ; 23: 189-91.
79. ARMSTRONG AA, ALEXANDER FE, PINTO PA ES R et al. Association of Epstein-Barr virus with pediatrie Hodgkin's disease. Am J Pathol 1993 ; 142 : 1683-8.
80. KNECHT H, BACHMANN E, JOSKE DJL et al. Molecular analysis of the LMP (latent membran protein) oncogen in Hodgkin's disease. Leukemia 1993 ; 7: 580-7.
81. BELLAS C, SANTON A, MANZANAL A, CAMPO E, MARTIN C, ACEVEDO A et al. Pathological, immunological and molecular features of Hodgkin's disease associated with HIV infection. Am J Stirg Pathol 1996 ; 20: 1520-4.
82. KUMAR S, KINGMA DW, WEISS WB, RAFFELD M, JAFFE ES. Primary cutaneous Hodgkin's disease with evolution to systemic disease. Association with the Epstein-Barr virus. Am J Surs Pathol 1996 ; 20: 754-9.
83. D'AMOKE F, JOHANSEN P, HouRMAND A et al. For the Danish Lymphoma Study group, LYFO. Epstcin-Barr virus genome in non-Hodgkin's lymphomas occuring in immunocompetcnt patients : highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Blood 1996 ; 87 : 1045-55.
84. DE BRUIN PC, JIWA NM, VAN DER VALK P et al. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas : relation between latent membrane protein-1 positivity and clinical course. Ilistopaihology 1993 ; 23: 509-18.
85. EMILE JF, BOULLAND ML, HAIOUN C et al. CDS- CD56 + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphoma. Blood 1996 ; 87 (4) : 1466-73.
86. KANAVAROS P, LESC MC, BRIèRE J et al. Nasal T-cell lymphoma : A clinicopathologic entity associated with peculiar phenotype and with EBV. Blood 1993 ; 81: 2688-95.
87. Su IJ, HSIEH HC, LIN KH el al. Aggresive peripheral T-cell lymphomas containing Epstein-Barr viral DNA : A clinicopathologic and molecular analysis. Blood 1991 ; 77: 799-808.
88. HARABUCHI Y, IMAI S, YAMANAKA N et al. Epstein-Barr virus in nasal T-ccll lymphomas in patients with lethal midline granuloma. Lancet 1990 ; 335 : 128-30.
89. VELTRI RW, RAICH PC, MAC CLUNG JE, SHAH SH, SPRINKLE PM. Lymphomatoid granulomatosis and Epstein-Barr virus. Cancer 19S2 ; 50: 1513-7.
90. MYERS JL, KURTIN PJ, KATZENSTEIN AL, TAZELAAR HD, COLBY TV, STRICKLER JG et al. Lymphomatoid granulomatosis. Am J Snrg Patlwl 1995 ; 19 (11) : 1300-12.
91. DE BRUIN PC, JIWA NM, OUDEJANS JJ et al. Presence of Epstein-Barr virus in extra-nodal T-ccll lymphomas : differences in relation to site. Blood 1994 ; 83: 1612-18.
92. HAMILTON-DUTOIT S, PALLESEN G. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Patlwl 1992 ; 140: 1315-25.
93. WEISS LM, JAFFE ES, Liu XF, CHEN YY, SHIBATA D, Medeiros J. Detection and localization of Epstein-Barr genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992 ; 79: 1789-95.
94. LOKE SL, Ho F, SRIVASTAVA G et al. Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineage. Am J Pathol 1992.140: 9S1-9.
95. CRAIG FE, CLARE CN, SKLAR JL, BANKS PM. T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol 1992 ; 97: 189-94.
96. NAKAMURA S, UEKI T, YAO T, UEYAMA T, TSUNEYOSHI M. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Cancer 1994 ; 73 : 2239-49.
97. YUEN ST, CIIUNG LP, LEUNG SY et al. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Stirg Patlwl 1994.18: 1158-63.
98. YI LEUNG S, TSAN YUEN S, PING CHUNG L et al. Epstein-Barr virus is present in a wide histological spectrum of sinonasal carcinomas. Am J Surg Palhol 1995 ; 19: 994-1001.
99. COURTADE M, BROUSSET P, DELSOL G. Détection simultanée de papillomavirus humains et du virus d'Epstein-Barr en cycle lytique dans des lésions de leucoplasie orale chevelue par hybridation in situ non isotopique. Ann Palhol 1992 ; 12:353-57.
100. REGAUD C, REVERCHON L. Sur un cas d'épithélioma épidermoide développé dans le massif maxillaire supérieur étendu aux ligaments de la face, aux cavités buccale, nasale, et orbitaire ainsi qu'aux ganglions du cou guéri par la radiothérapie. Rev Laryngol 1921 ; 42: 3.
101. SHAO YM, POIRIER S et ni. Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for naso-pharyngeal carcinomas. Carcinogenesis 1988; 9: 1455-7.
102. HUANG DP, No HK, Ho YH et al. Epstein-Barr virus-associated undifferenciated carcinoma of the parotid gland. Histopatlwlogy 1988 ; 13: 509-17.
103. LEYVAZ S, HENLé W, CHAIIINIAN P et al. Association of Epstein-Barr virus with thymic carcinoma. A' Engl J Mcd 1985 ; 312 : 1296-9.
104. DIMERY IW, LEE JS, BLICK M, PEARSON G, SPITZER G et HONG WK. Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer 1988 ; 6l : 2475-80.
105. PITTALUGA S, WONG MP, CHUNG LP, LORE SL. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung. Am J Snrg Palhol 1993 ; 17 (7) : 678-89.
106. LOPATEGUI JR, GAFFEY MJ, FRIERSON HF et al. Detection of Epstein-Barr viral RNA in sinonasal undifferenciated carcinoma from Western and Asian patients. Am J Surg Palhol 1994.75:391-8.
107. LEE ES, LOCKER J, NALESNIK M et al. The association of Epstein-Barr virus with smooth-muscle tumors occuring after organ transplantation. A' Eng J Med 1995 ; 332 : 19-25.
108. Me CLAIN KL, LEACH CT, JENSON HB et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Eng J Med 1995 ; 332 : 12-8.
109. LE BAIL B, MOREL D, MéREL P, COMEAU F, MERLIO JP, CARLES J et al. Cystic smooth-muscle tumor of the liver and spleen associated with Epstein-Barr virus after renal transplantation. Am J Surg Patlwl 1996 ; 20 (11) : 1418-25.